U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Regeneron Pharmaceuticals

Market Cap: US$61.1b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Exact Sciences

Market Cap: US$9.0b

Provides cancer screening and diagnostic test products in the United States and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.6b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Jazz Pharmaceuticals

Market Cap: US$7.5b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$20.8b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Decibel Cannabis

Market Cap: US$75.0m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Evolus

Market Cap: US$496.8m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Journey Medical

Market Cap: US$182.1m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

ICON

Market Cap: US$13.7b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Amneal Pharmaceuticals

Market Cap: US$3.0b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Perrigo

Market Cap: US$3.3b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Sanofi

Market Cap: US$105.2b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Cresco Labs

Market Cap: US$760.9m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Evotec

Market Cap: US$1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Amphastar Pharmaceuticals

Market Cap: US$1.4b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Viatris

Market Cap: US$12.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Travere Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

UroGen Pharma

Market Cap: US$899.4m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Abeona Therapeutics

Market Cap: US$370.7m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Protara Therapeutics

Market Cap: US$120.0m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Organon

Market Cap: US$2.4b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Royalty Pharma

Market Cap: US$21.0b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Bayer

Market Cap: US$27.6b

Operates as a life science company worldwide.

Merck KGaA

Market Cap: US$47.8b

Operates as a science and technology company in Germany.

Halozyme Therapeutics

Market Cap: US$8.4b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Sarepta Therapeutics

Market Cap: US$2.0b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

AVITA Medical

Market Cap: US$146.5m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Biogen

Market Cap: US$20.4b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Curaleaf Holdings

Market Cap: US$3.2b

Produces and distributes cannabis products in the United States and internationally.

Trulieve Cannabis

Market Cap: US$2.3b

Operates as a cannabis retailer.

Avantor

Market Cap: US$9.0b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Cosmo Pharmaceuticals

Market Cap: US$929.2m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$2.5b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Otsuka Holdings

Market Cap: US$4.2t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Puma Biotechnology

Market Cap: US$264.4m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.